文献速递肺外科

肺减容术后再行内镜下活瓣治疗的安全性与可行性

Lung volume reduction surgery is safe and feasible after initial endobronchial valve treatment for emphysema patients.
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2024-01-01

本研究为单中心回顾性研究,纳入21例既往接受内镜下活瓣治疗后又行择期肺叶切除术的晚期肺气肿患者。结果显示无90天死亡及术后重症监护入住,肺部感染和 prolonged air leak 各占14%,因疗效丧失手术者肺功能显著改善。

要点

  • 内镜下活瓣治疗后择期肺叶切除术无90天死亡,未发生术后重症监护入住。
  • 最常见并发症为肺部感染(14%)和 prolonged air leak(14%)。
  • 因疗效丧失手术者FEV1、FVC显著改善,残气量显著降低。

核心结论

  • 内镜下活瓣治疗后再行择期肺叶切除术安全可行,并恢复肺减容效果。

研究设计与样本

  • 单中心回顾性研究,纳入21例既往接受内镜下活瓣治疗后行择期肺叶切除术的患者。

主要发现

  • 无90天死亡,无术后重症监护入住。
  • 肺部感染(14%)和 prolonged air leak(14%)为最常见并发症。
  • 因疗效丧失或缺乏手术者,肺叶切除后FEV1中位改善+75(193)ml(P < 0.013),FVC +450(572)ml(P = 0.001),残气量-665(715)ml(P = 0.005)。
  • 因活瓣治疗并发症手术者,术后所有并发症均缓解。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Bronchoscopic lung volume reduction with endobronchial valves is a guideline treatment leading to improved pulmonary function, exercise tolerance and quality of life, in patients with advanced emphysema, severe hyperinflation and no collateral ventilation. After valve treatment, loss of the initial lung volume reduction effect can occur, as well as local valve-induced complications such as persistent haemoptysis. In these cases, a surgical lobectomy can be considered to achieve similar efficacy outcomes. We evaluated the safety and feasibility of a video-assisted thoracoscopic surgery lobectomy after valve treatment. METHODS: This single-centre retrospective study included patients who underwent an elective lobectomy after previous valve treatment. Data were evaluated for safety and efficacy for the additional surgical procedure. RESULTS: Twenty-one patients [73% female, median age 67 (7) years, forced expiratory volume in 1 s 29 (7) %pred, and residual volume 223 (58) %pred] were included. There was no 90-day mortality and there were no postoperative intensive care admissions. Pulmonary infections (14%) and prolonged air leak (14%) were the most common complications. In patients who underwent surgery due to loss or lack of effect of valve treatment, a lobectomy led to a significant improvement in pulmonary function; median forced expiratory volume in 1 s +75 (193) ml (P < 0.013), forced vital capacity +450 (572) ml (P = 0.001), residual volume -665 (715) ml (P = 0.005). In patients who underwent a lobectomy because of complications of valve treatment, all complications were resolved after surgery. CONCLUSIONS: We demonstrate that an elective lobectomy after an initial valve treatment is safe and feasible and restores the lung volume reduction effect.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Van Dijk M, Van De Wauwer C, Koster TD, et al. Lung volume reduction surgery is safe and feasible after initial endobronchial valve treatment for emphysema patients. Interdiscip Cardiovasc Thorac Surg. 2024. PMID: 38724230. doi:10.1093/icvts/ivae094

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。